ArticleBMC women's health2026
Prevalence and associated factors of clinically significant symptoms of depression and anxiety among women with endometriosis in Iran.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing the frontiers of phytotherapy: a comprehensive review of botanical interventions targeting mitochondrial quality control to ameliorate endometriosis.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndometriosis is a prevalent chronic condition that causes persistent pelvic pain, significantly impairing quality of life and contributing to psychological distress. This study aimed to assess the prevalence of clinically significant symptoms of depression and anxiety among women with endometriosis and to identify factors associated with these mental health outcomes.
methodsThis cross-sectional study was conducted between 2023 and 2024 at Shahid Kamali Hospital, Karaj, Iran. Women with a confirmed diagnosis of endometriosis by a gynecologist were recruited using convenience sampling. Participants completed the Hospital Anxiety and Depression Scale (HADS), a validated self-report screening tool, and clinical data were extracted from medical records. Univariate and multivariate logistic regression analyses were performed to identify demographic and clinical factors associated with clinically significant symptoms of depression and anxiety.
resultsA total of 112 women participated (mean age: 31.6 ± 4.9 years; mean BMI: 26.3 ± 3.7 kg/m²). The prevalence of clinically significant symptoms of depression and anxiety was 59.8% (95% CI: 50.4-68.6) and 54.5% (95% CI: 45.1-63.6), respectively. Univariate analyses showed that longer disease duration and higher pain intensity were significantly associated with depression, while education level was associated with anxiety. No significant association was found between endometriosis severity and either outcome. In the multivariate model, age, disease duration, and pain intensity remained significant correlates of depression, while education level and age were associated with anxiety.
conclusionsClinically significant symptoms of depression and anxiety were highly prevalent among women with endometriosis. Disease duration and pain intensity were the main factors associated with depressive symptoms, while education level was linked to anxiety. These findings emphasize the need for integrated physical and psychological care for women with endometriosis, particularly those experiencing prolonged disease and chronic pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.